MOTION FOR A RESOLUTION on the vaccine against salmonella

3.1.2017

pursuant to Rule 133 of the Rules of Procedure

Mireille D’Ornano

B8-0012/2017

Motion for a European Parliament resolution on the vaccine against salmonella

The European Parliament,

–  having regard to Article 168 of the Treaty on the Functioning of the European Union,

–  having regard to Rule 133 of its Rules of Procedure,

A.  whereas diarrhoeal diseases affect 550 million people every year; whereas salmonella, a type of bacteria in the Enterobacteriaceae family of which there are about 2500 serotypes, is one of the four biggest causes of diarrhoeal diseases and, in particular, salmonellosis;

B.  whereas, in 2015, 94 625 cases of salmonellosis were detected in the 28 EU Member States – the equivalent of 21.2 cases per 100 000 persons, which is 1.9% more than in 2014; whereas, according to the World Health Organisation, the migrant crisis has contributed to that increase;

C.  whereas salmonellosis is treated using antibiotics but, according to the US Center for Disease Control and Surveillance, about 10% of salmonella infections were resistant to antibiotics in 2015;

D.  whereas a study carried out by the University of Texas (Galveston, US, 14 December 2016) led to the creation of an oral vaccine;

1.  Calls on the Commission to support research and make it possible for a vaccine against salmonellosis to be brought onto the EU market if need be.